The main aim of treatment for chronic hepatitis
B is to suppress HBV replication before there is irreversible liver damage
alfa was the first treatment approved in most countries. It leads to a beneficial response in 30 to 40 percent of patients, but is expensive, and may be accompanied by unpleasant side effects. Many antiviral therapies have shown promise, and may have a key role in the treatment of chronic hepatitis B. One of these is lamivudine
. Consult an expert in Infectious Diseases and keep in constant touch to bring about a cure. Take Care.